

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.75074292 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 5.75074292 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.53237637 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 5.53237637 |
| 5 | alpha-linolenic acid metabolic process (GO:0036109) | 5.28333378 |
| 6 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.10237261 |
| 7 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.98032416 |
| 8 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.93291438 |
| 9 | aromatic amino acid family catabolic process (GO:0009074) | 4.92391136 |
| 10 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.90266090 |
| 11 | cysteine metabolic process (GO:0006534) | 4.69595417 |
| 12 | kynurenine metabolic process (GO:0070189) | 4.57308795 |
| 13 | urea cycle (GO:0000050) | 4.55418630 |
| 14 | urea metabolic process (GO:0019627) | 4.55418630 |
| 15 | negative regulation of fibrinolysis (GO:0051918) | 4.48315065 |
| 16 | sulfur amino acid catabolic process (GO:0000098) | 4.48279362 |
| 17 | lysine metabolic process (GO:0006553) | 4.40620389 |
| 18 | lysine catabolic process (GO:0006554) | 4.40620389 |
| 19 | bile acid biosynthetic process (GO:0006699) | 4.37033325 |
| 20 | complement activation, alternative pathway (GO:0006957) | 4.34096315 |
| 21 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.32864727 |
| 22 | regulation of cholesterol homeostasis (GO:2000188) | 4.32843473 |
| 23 | glyoxylate metabolic process (GO:0046487) | 4.30623497 |
| 24 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.27970297 |
| 25 | protein carboxylation (GO:0018214) | 4.23819201 |
| 26 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.23819201 |
| 27 | indole-containing compound catabolic process (GO:0042436) | 4.22598719 |
| 28 | indolalkylamine catabolic process (GO:0046218) | 4.22598719 |
| 29 | tryptophan catabolic process (GO:0006569) | 4.22598719 |
| 30 | high-density lipoprotein particle remodeling (GO:0034375) | 4.21915314 |
| 31 | regulation of protein activation cascade (GO:2000257) | 4.18776567 |
| 32 | serine family amino acid catabolic process (GO:0009071) | 4.10701229 |
| 33 | nitrogen cycle metabolic process (GO:0071941) | 4.10369097 |
| 34 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.05053415 |
| 35 | negative regulation of cell killing (GO:0031342) | 4.05053415 |
| 36 | regulation of triglyceride catabolic process (GO:0010896) | 3.98568255 |
| 37 | regulation of fibrinolysis (GO:0051917) | 3.98503125 |
| 38 | tryptophan metabolic process (GO:0006568) | 3.96391782 |
| 39 | regulation of complement activation (GO:0030449) | 3.96202920 |
| 40 | negative regulation of sterol transport (GO:0032372) | 3.95641452 |
| 41 | negative regulation of cholesterol transport (GO:0032375) | 3.95641452 |
| 42 | homocysteine metabolic process (GO:0050667) | 3.85656030 |
| 43 | bile acid metabolic process (GO:0008206) | 3.85197883 |
| 44 | reverse cholesterol transport (GO:0043691) | 3.82623962 |
| 45 | plasma lipoprotein particle clearance (GO:0034381) | 3.82584584 |
| 46 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.76838332 |
| 47 | phospholipid efflux (GO:0033700) | 3.75242058 |
| 48 | amino-acid betaine metabolic process (GO:0006577) | 3.69792344 |
| 49 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.69367841 |
| 50 | glutamate metabolic process (GO:0006536) | 3.69297329 |
| 51 | acylglycerol homeostasis (GO:0055090) | 3.68268005 |
| 52 | triglyceride homeostasis (GO:0070328) | 3.68268005 |
| 53 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.61456336 |
| 54 | ethanol oxidation (GO:0006069) | 3.59452492 |
| 55 | tyrosine metabolic process (GO:0006570) | 3.55584594 |
| 56 | cellular modified amino acid catabolic process (GO:0042219) | 3.54814829 |
| 57 | 2-oxoglutarate metabolic process (GO:0006103) | 3.52093245 |
| 58 | positive regulation of lipid catabolic process (GO:0050996) | 3.51423945 |
| 59 | aromatic amino acid family metabolic process (GO:0009072) | 3.51014967 |
| 60 | alpha-amino acid catabolic process (GO:1901606) | 3.50933130 |
| 61 | protein-lipid complex remodeling (GO:0034368) | 3.50334933 |
| 62 | macromolecular complex remodeling (GO:0034367) | 3.50334933 |
| 63 | plasma lipoprotein particle remodeling (GO:0034369) | 3.50334933 |
| 64 | phospholipid homeostasis (GO:0055091) | 3.49440466 |
| 65 | cholesterol efflux (GO:0033344) | 3.43695140 |
| 66 | plasma lipoprotein particle assembly (GO:0034377) | 3.42928553 |
| 67 | cellular ketone body metabolic process (GO:0046950) | 3.40199335 |
| 68 | protein-lipid complex assembly (GO:0065005) | 3.40084613 |
| 69 | acetyl-CoA metabolic process (GO:0006084) | 3.39268019 |
| 70 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.37251699 |
| 71 | regulation of cholesterol esterification (GO:0010872) | 3.36161208 |
| 72 | glycine metabolic process (GO:0006544) | 3.29463100 |
| 73 | cellular amino acid catabolic process (GO:0009063) | 3.29172252 |
| 74 | drug catabolic process (GO:0042737) | 3.26051699 |
| 75 | bile acid and bile salt transport (GO:0015721) | 3.24310996 |
| 76 | aspartate family amino acid catabolic process (GO:0009068) | 3.23833730 |
| 77 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.22423858 |
| 78 | serine family amino acid metabolic process (GO:0009069) | 3.21776100 |
| 79 | valine metabolic process (GO:0006573) | 3.21573435 |
| 80 | short-chain fatty acid metabolic process (GO:0046459) | 3.20829145 |
| 81 | response to interleukin-15 (GO:0070672) | 3.16259926 |
| 82 | cholesterol homeostasis (GO:0042632) | 3.14827912 |
| 83 | low-density lipoprotein particle clearance (GO:0034383) | 3.13391745 |
| 84 | sterol homeostasis (GO:0055092) | 3.12440598 |
| 85 | complement activation, classical pathway (GO:0006958) | 3.09757174 |
| 86 | response to type I interferon (GO:0034340) | 3.08508955 |
| 87 | cellular response to interleukin-15 (GO:0071350) | 3.08244852 |
| 88 | macroautophagy (GO:0016236) | 3.08114932 |
| 89 | type I interferon signaling pathway (GO:0060337) | 3.06878664 |
| 90 | cellular response to type I interferon (GO:0071357) | 3.06878664 |
| 91 | fatty acid transmembrane transport (GO:1902001) | 3.06469334 |
| 92 | mannose metabolic process (GO:0006013) | 3.03367076 |
| 93 | cytolysis (GO:0019835) | 3.03305404 |
| 94 | ketone body metabolic process (GO:1902224) | 3.03038220 |
| 95 | complement activation (GO:0006956) | 3.02503620 |
| 96 | N-glycan processing (GO:0006491) | 3.01996311 |
| 97 | fatty acid beta-oxidation (GO:0006635) | 3.01503212 |
| 98 | activated T cell proliferation (GO:0050798) | 3.01491387 |
| 99 | fatty acid oxidation (GO:0019395) | 3.00961341 |
| 100 | benzene-containing compound metabolic process (GO:0042537) | 3.00736405 |
| 101 | positive regulation of fatty acid oxidation (GO:0046321) | 3.00715723 |
| 102 | regulation of bile acid biosynthetic process (GO:0070857) | 3.00082897 |
| 103 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.99599232 |
| 104 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.99599232 |
| 105 | fibrinolysis (GO:0042730) | 2.97217659 |
| 106 | negative regulation of lipase activity (GO:0060192) | 2.96605398 |
| 107 | lipoprotein metabolic process (GO:0042157) | 2.95046809 |
| 108 | coenzyme catabolic process (GO:0009109) | 2.95031318 |
| 109 | lipid oxidation (GO:0034440) | 2.94048948 |
| 110 | intestinal cholesterol absorption (GO:0030299) | 2.90901829 |
| 111 | drug transmembrane transport (GO:0006855) | 2.90528025 |
| 112 | cellular glucuronidation (GO:0052695) | 2.88623353 |
| 113 | organic acid catabolic process (GO:0016054) | 2.88548321 |
| 114 | carboxylic acid catabolic process (GO:0046395) | 2.88548321 |
| 115 | protein-lipid complex subunit organization (GO:0071825) | 2.86817751 |
| 116 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.86497855 |
| 117 | negative T cell selection (GO:0043383) | 2.81780813 |
| 118 | negative thymic T cell selection (GO:0045060) | 2.78089129 |
| 119 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.77881359 |
| 120 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.74393531 |
| 121 | N-acetylneuraminate metabolic process (GO:0006054) | 2.70577656 |
| 122 | phosphatidylethanolamine biosynthetic process (GO:0006646) | 2.64866795 |
| 123 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.63505756 |
| 124 | iron ion import (GO:0097286) | 2.62416420 |
| 125 | positive T cell selection (GO:0043368) | 2.60202063 |
| 126 | interferon-gamma production (GO:0032609) | 2.59144404 |
| 127 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.57309259 |
| 128 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.53251943 |
| 129 | tolerance induction (GO:0002507) | 2.52621430 |
| 130 | T cell selection (GO:0045058) | 2.51777941 |
| 131 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.48240604 |
| 132 | regulation of metalloenzyme activity (GO:0048552) | 2.48175139 |
| 133 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.44662133 |
| 134 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.44662133 |
| 135 | detection of other organism (GO:0098543) | 2.44540297 |
| 136 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.44458239 |
| 137 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.44215760 |
| 138 | phosphatidylethanolamine metabolic process (GO:0046337) | 2.44026454 |
| 139 | detection of bacterium (GO:0016045) | 2.43475189 |
| 140 | regulation of defense response to virus by virus (GO:0050690) | 2.42966699 |
| 141 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.42138137 |
| 142 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.40154514 |
| 143 | phosphatidylglycerol biosynthetic process (GO:0006655) | 2.39536977 |
| 144 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.38691694 |
| 145 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.38525634 |
| 146 | modulation by symbiont of host immune response (GO:0052553) | 2.38525634 |
| 147 | positive regulation by symbiont of host defense response (GO:0052509) | 2.38525634 |
| 148 | modulation by symbiont of host defense response (GO:0052031) | 2.38525634 |
| 149 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.38525634 |
| 150 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.38525634 |
| 151 | hepatocyte apoptotic process (GO:0097284) | 2.37963325 |
| 152 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.37641340 |
| 153 | detection of external biotic stimulus (GO:0098581) | 2.37623632 |
| 154 | positive regulation of cell killing (GO:0031343) | 2.36122677 |
| 155 | protein localization to endosome (GO:0036010) | 2.35216017 |
| 156 | establishment of protein localization to Golgi (GO:0072600) | 2.34953622 |
| 157 | protein targeting to Golgi (GO:0000042) | 2.34126159 |
| 158 | mitochondrial outer membrane permeabilization involved in programmed cell death (GO:1902686) | 2.30959417 |
| 159 | positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110 | 2.30959417 |
| 160 | detection of molecule of bacterial origin (GO:0032490) | 2.29828952 |
| 161 | negative regulation of innate immune response (GO:0045824) | 2.29398689 |
| 162 | thymic T cell selection (GO:0045061) | 2.28845322 |
| 163 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.28108833 |
| 164 | negative regulation of protein activation cascade (GO:2000258) | 2.27462673 |
| 165 | regulation of cell killing (GO:0031341) | 2.27316346 |
| 166 | necrotic cell death (GO:0070265) | 2.27163837 |
| 167 | regulation of extracellular matrix disassembly (GO:0010715) | 2.23850755 |
| 168 | amyloid precursor protein catabolic process (GO:0042987) | 2.23668015 |
| 169 | negative regulation of glycoprotein metabolic process (GO:1903019) | 2.21524063 |
| 170 | macrophage activation involved in immune response (GO:0002281) | 2.20423434 |
| 171 | leukocyte aggregation (GO:0070486) | 2.19902716 |
| 172 | programmed necrotic cell death (GO:0097300) | 2.19417005 |
| 173 | cell wall macromolecule catabolic process (GO:0016998) | 2.19329975 |
| 174 | receptor recycling (GO:0001881) | 2.18968777 |
| 175 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.18938226 |
| 176 | cardiolipin metabolic process (GO:0032048) | 2.18845255 |
| 177 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.16787865 |
| 178 | T-helper cell differentiation (GO:0042093) | 2.16787865 |
| 179 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.16509127 |
| 180 | positive regulation of mitochondrial membrane permeability (GO:0035794) | 2.15643448 |
| 181 | T cell migration (GO:0072678) | 2.15479800 |
| 182 | necroptotic process (GO:0070266) | 2.13637185 |
| 183 | regulation of memory T cell differentiation (GO:0043380) | 2.13192761 |
| 184 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.11292602 |
| 185 | negative regulation of complement activation (GO:0045916) | 2.11238243 |
| 186 | positive regulation of interferon-alpha production (GO:0032727) | 2.11139322 |
| 187 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.10411494 |
| 188 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.10285077 |
| 189 | regulation of interleukin-5 production (GO:0032674) | 2.09258208 |
| 190 | B cell homeostasis (GO:0001782) | 2.09108917 |
| 191 | mitochondrial calcium ion transport (GO:0006851) | 2.08705730 |
| 192 | T cell differentiation involved in immune response (GO:0002292) | 2.07858694 |
| 193 | alpha-beta T cell activation involved in immune response (GO:0002287) | 2.07858694 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 7.74619973 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.69578211 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.13896524 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.61695671 |
| 5 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 4.52629908 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.20943593 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.46999271 |
| 8 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.19518249 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.10637580 |
| 10 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.66769616 |
| 11 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.52523551 |
| 12 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.45901774 |
| 13 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.34264585 |
| 14 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.32766533 |
| 15 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.27054408 |
| 16 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.19580731 |
| 17 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.13040766 |
| 18 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.03024846 |
| 19 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.00055094 |
| 20 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.91637606 |
| 21 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.90926475 |
| 22 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.81740339 |
| 23 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.78239503 |
| 24 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.74119630 |
| 25 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.73972496 |
| 26 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.73225367 |
| 27 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.71651772 |
| 28 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.71485284 |
| 29 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.70960554 |
| 30 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.69833943 |
| 31 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.68941622 |
| 32 | MYC_22102868_ChIP-Seq_BL_Human | 1.64940054 |
| 33 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.63366131 |
| 34 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.62759832 |
| 35 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.62430430 |
| 36 | MAF_26560356_Chip-Seq_TH2_Human | 1.61873596 |
| 37 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.61442691 |
| 38 | MYB_26560356_Chip-Seq_TH1_Human | 1.60227505 |
| 39 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.57276013 |
| 40 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.55206665 |
| 41 | SPI1_23127762_ChIP-Seq_K562_Human | 1.54573229 |
| 42 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.49919182 |
| 43 | MYB_26560356_Chip-Seq_TH2_Human | 1.49311184 |
| 44 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.48842624 |
| 45 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.48241863 |
| 46 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.48230438 |
| 47 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.44882448 |
| 48 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.43755921 |
| 49 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.43447461 |
| 50 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.41843528 |
| 51 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.40085362 |
| 52 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.39901913 |
| 53 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.36111334 |
| 54 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.35650265 |
| 55 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.35175603 |
| 56 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.34313305 |
| 57 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.33296989 |
| 58 | GATA1_19941826_ChIP-Seq_K562_Human | 1.32685234 |
| 59 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.30875027 |
| 60 | GATA1_22025678_ChIP-Seq_K562_Human | 1.30177187 |
| 61 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.29686764 |
| 62 | KDM2B_26808549_Chip-Seq_K562_Human | 1.28505989 |
| 63 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.27685343 |
| 64 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.26615210 |
| 65 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.25210825 |
| 66 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.23639188 |
| 67 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.21979640 |
| 68 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.18777390 |
| 69 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.17141856 |
| 70 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.16116003 |
| 71 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14878778 |
| 72 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.13381054 |
| 73 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.12571648 |
| 74 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.11906613 |
| 75 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.10199267 |
| 76 | P300_27268052_Chip-Seq_Bcells_Human | 1.09175116 |
| 77 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.08782983 |
| 78 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.08715256 |
| 79 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.08672986 |
| 80 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.08148388 |
| 81 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.06891651 |
| 82 | MAF_26560356_Chip-Seq_TH1_Human | 1.06558441 |
| 83 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.06116211 |
| 84 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.04820352 |
| 85 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.02871235 |
| 86 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.02871235 |
| 87 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.02391426 |
| 88 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.01876428 |
| 89 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.01327918 |
| 90 | UTX_26944678_Chip-Seq_JUKART_Human | 1.01146432 |
| 91 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.00815261 |
| 92 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.00643047 |
| 93 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00459557 |
| 94 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.99343233 |
| 95 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.98491673 |
| 96 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.98458923 |
| 97 | GATA3_26560356_Chip-Seq_TH2_Human | 0.97940697 |
| 98 | ATF3_27146783_Chip-Seq_COLON_Human | 0.97728544 |
| 99 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.97602074 |
| 100 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.97569482 |
| 101 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.96970745 |
| 102 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.96075703 |
| 103 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.95960269 |
| 104 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.95900102 |
| 105 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.95837869 |
| 106 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.95431399 |
| 107 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.95375644 |
| 108 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.95332089 |
| 109 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.94825498 |
| 110 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.94467421 |
| 111 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.94050509 |
| 112 | P68_20966046_ChIP-Seq_HELA_Human | 0.93562152 |
| 113 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.92986825 |
| 114 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.92193319 |
| 115 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.91706030 |
| 116 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.90705642 |
| 117 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.90633599 |
| 118 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.89932376 |
| 119 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.88714553 |
| 120 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.87651780 |
| 121 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.87544550 |
| 122 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.85449785 |
| 123 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.85144885 |
| 124 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.85037944 |
| 125 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.85022804 |
| 126 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.84500015 |
| 127 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.84495743 |
| 128 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.84008123 |
| 129 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.83636937 |
| 130 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.83284924 |
| 131 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.83226098 |
| 132 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.82951258 |
| 133 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.82623493 |
| 134 | * SMC4_20622854_ChIP-Seq_HELA_Human | 0.82537042 |
| 135 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.81305107 |
| 136 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.80465451 |
| 137 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.80320166 |
| 138 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.80133151 |
| 139 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.79202560 |
| 140 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.79143463 |
| 141 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.79128058 |
| 142 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.78604123 |
| 143 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.78507703 |
| 144 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.76942852 |
| 145 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.76594011 |
| 146 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.76155148 |
| 147 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.74946422 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.60982695 |
| 2 | MP0005360_urolithiasis | 6.33045051 |
| 3 | MP0005365_abnormal_bile_salt | 5.03661061 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 4.85795327 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 3.72027609 |
| 6 | MP0003252_abnormal_bile_duct | 3.51868256 |
| 7 | MP0009840_abnormal_foam_cell | 3.40148649 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.30830035 |
| 9 | MP0003763_abnormal_thymus_physiology | 3.10418540 |
| 10 | MP0003724_increased_susceptibility_to | 3.00899704 |
| 11 | MP0003705_abnormal_hypodermis_morpholog | 2.96604032 |
| 12 | MP0005083_abnormal_biliary_tract | 2.90149000 |
| 13 | MP0003436_decreased_susceptibility_to | 2.50905284 |
| 14 | MP0001666_abnormal_nutrient_absorption | 2.49681132 |
| 15 | MP0003191_abnormal_cellular_cholesterol | 2.49330351 |
| 16 | MP0003806_abnormal_nucleotide_metabolis | 2.45207024 |
| 17 | MP0005671_abnormal_response_to | 2.41572837 |
| 18 | MP0005387_immune_system_phenotype | 2.32402895 |
| 19 | MP0001790_abnormal_immune_system | 2.32402895 |
| 20 | MP0010234_abnormal_vibrissa_follicle | 2.23312238 |
| 21 | MP0000609_abnormal_liver_physiology | 2.21499955 |
| 22 | MP0005332_abnormal_amino_acid | 2.19867308 |
| 23 | MP0003300_gastrointestinal_ulcer | 2.07268146 |
| 24 | MP0002118_abnormal_lipid_homeostasis | 2.02729972 |
| 25 | MP0002138_abnormal_hepatobiliary_system | 1.93566402 |
| 26 | MP0001800_abnormal_humoral_immune | 1.92423569 |
| 27 | MP0008260_abnormal_autophagy | 1.86988985 |
| 28 | MP0003195_calcinosis | 1.85107740 |
| 29 | MP0005025_abnormal_response_to | 1.81335529 |
| 30 | MP0009333_abnormal_splenocyte_physiolog | 1.76586068 |
| 31 | MP0002723_abnormal_immune_serum | 1.75518501 |
| 32 | MP0004130_abnormal_muscle_cell | 1.74894956 |
| 33 | MP0004019_abnormal_vitamin_homeostasis | 1.73444623 |
| 34 | MP0002419_abnormal_innate_immunity | 1.61507654 |
| 35 | MP0005379_endocrine/exocrine_gland_phen | 1.61212204 |
| 36 | MP0004185_abnormal_adipocyte_glucose | 1.60793357 |
| 37 | MP0005319_abnormal_enzyme/_coenzyme | 1.58288066 |
| 38 | MP0002420_abnormal_adaptive_immunity | 1.57571750 |
| 39 | MP0001835_abnormal_antigen_presentation | 1.56595487 |
| 40 | MP0001819_abnormal_immune_cell | 1.55264979 |
| 41 | MP0002452_abnormal_antigen_presenting | 1.54358916 |
| 42 | MP0009785_altered_susceptibility_to | 1.54317219 |
| 43 | MP0003303_peritoneal_inflammation | 1.52524156 |
| 44 | MP0000604_amyloidosis | 1.51375030 |
| 45 | MP0003868_abnormal_feces_composition | 1.48913807 |
| 46 | MP0005000_abnormal_immune_tolerance | 1.48178087 |
| 47 | MP0004381_abnormal_hair_follicle | 1.47246670 |
| 48 | MP0008961_abnormal_basal_metabolism | 1.45724405 |
| 49 | MP0005666_abnormal_adipose_tissue | 1.44676626 |
| 50 | MP0001533_abnormal_skeleton_physiology | 1.43564691 |
| 51 | MP0001348_abnormal_lacrimal_gland | 1.42913433 |
| 52 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.40724305 |
| 53 | MP0001845_abnormal_inflammatory_respons | 1.39859031 |
| 54 | MP0009643_abnormal_urine_homeostasis | 1.37015141 |
| 55 | MP0003866_abnormal_defecation | 1.34101029 |
| 56 | MP0005310_abnormal_salivary_gland | 1.31274240 |
| 57 | MP0002876_abnormal_thyroid_physiology | 1.28709747 |
| 58 | MP0010155_abnormal_intestine_physiology | 1.26916524 |
| 59 | MP0003183_abnormal_peptide_metabolism | 1.24665670 |
| 60 | MP0001873_stomach_inflammation | 1.21595714 |
| 61 | MP0002148_abnormal_hypersensitivity_rea | 1.21556262 |
| 62 | MP0002933_joint_inflammation | 1.21059405 |
| 63 | MP0005670_abnormal_white_adipose | 1.20373220 |
| 64 | MP0003329_amyloid_beta_deposits | 1.20109581 |
| 65 | MP0000716_abnormal_immune_system | 1.18421447 |
| 66 | MP0003656_abnormal_erythrocyte_physiolo | 1.17806080 |
| 67 | MP0002254_reproductive_system_inflammat | 1.17700613 |
| 68 | MP0000689_abnormal_spleen_morphology | 1.17451340 |
| 69 | MP0002405_respiratory_system_inflammati | 1.16764589 |
| 70 | MP0000598_abnormal_liver_morphology | 1.13706512 |
| 71 | MP0005075_abnormal_melanosome_morpholog | 1.11043628 |
| 72 | MP0005058_abnormal_lysosome_morphology | 1.09418017 |
| 73 | MP0001851_eye_inflammation | 1.08682137 |
| 74 | MP0002971_abnormal_brown_adipose | 1.07096215 |
| 75 | MP0005451_abnormal_body_composition | 1.06315441 |
| 76 | MP0002398_abnormal_bone_marrow | 1.06226456 |
| 77 | MP0005375_adipose_tissue_phenotype | 1.05908757 |
| 78 | MP0003787_abnormal_imprinting | 1.05093184 |
| 79 | MP0001661_extended_life_span | 1.01292152 |
| 80 | MP0002693_abnormal_pancreas_physiology | 1.01283532 |
| 81 | MP0000015_abnormal_ear_pigmentation | 0.98879598 |
| 82 | MP0002078_abnormal_glucose_homeostasis | 0.96905678 |
| 83 | MP0003690_abnormal_glial_cell | 0.94561802 |
| 84 | MP0002163_abnormal_gland_morphology | 0.94441776 |
| 85 | MP0002722_abnormal_immune_system | 0.92706985 |
| 86 | MP0010368_abnormal_lymphatic_system | 0.91920378 |
| 87 | MP0004947_skin_inflammation | 0.90820571 |
| 88 | MP0003123_paternal_imprinting | 0.89858499 |
| 89 | MP0002429_abnormal_blood_cell | 0.89346130 |
| 90 | MP0001756_abnormal_urination | 0.85601745 |
| 91 | MP0003011_delayed_dark_adaptation | 0.85250475 |
| 92 | MP0001849_ear_inflammation | 0.85197994 |
| 93 | MP0005334_abnormal_fat_pad | 0.85177466 |
| 94 | MP0002796_impaired_skin_barrier | 0.81255526 |
| 95 | MP0003566_abnormal_cell_adhesion | 0.79282525 |
| 96 | MP0000858_altered_metastatic_potential | 0.79191581 |
| 97 | MP0000465_gastrointestinal_hemorrhage | 0.78772545 |
| 98 | MP0005220_abnormal_exocrine_pancreas | 0.78047510 |
| 99 | MP0000538_abnormal_urinary_bladder | 0.77516577 |
| 100 | MP0002009_preneoplasia | 0.77369159 |
| 101 | MP0009642_abnormal_blood_homeostasis | 0.76577362 |
| 102 | MP0000703_abnormal_thymus_morphology | 0.75586062 |
| 103 | MP0005076_abnormal_cell_differentiation | 0.75452033 |
| 104 | MP0005167_abnormal_blood-brain_barrier | 0.74850510 |
| 105 | MP0004883_abnormal_blood_vessel | 0.74618552 |
| 106 | MP0009763_increased_sensitivity_to | 0.73661583 |
| 107 | MP0002136_abnormal_kidney_physiology | 0.71800398 |
| 108 | MP0005636_abnormal_mineral_homeostasis | 0.71473036 |
| 109 | MP0003453_abnormal_keratinocyte_physiol | 0.71424174 |
| 110 | MP0000003_abnormal_adipose_tissue | 0.71196983 |
| 111 | MP0002909_abnormal_adrenal_gland | 0.70481142 |
| 112 | MP0008469_abnormal_protein_level | 0.70295291 |
| 113 | MP0000747_muscle_weakness | 0.69708460 |
| 114 | MP0001764_abnormal_homeostasis | 0.69163212 |
| 115 | MP0003045_fibrosis | 0.65435159 |
| 116 | MP0004264_abnormal_extraembryonic_tissu | 0.64422140 |
| 117 | MP0009780_abnormal_chondrocyte_physiolo | 0.63581564 |
| 118 | MP0002166_altered_tumor_susceptibility | 0.62106140 |
| 119 | MP0005535_abnormal_body_temperature | 0.61741314 |
| 120 | MP0005464_abnormal_platelet_physiology | 0.61507075 |
| 121 | MP0003075_altered_response_to | 0.59764364 |
| 122 | MP0009672_abnormal_birth_weight | 0.59420220 |
| 123 | MP0005647_abnormal_sex_gland | 0.58715403 |
| 124 | MP0002928_abnormal_bile_duct | 0.57790052 |
| 125 | MP0004043_abnormal_pH_regulation | 0.57600465 |
| 126 | MP0000013_abnormal_adipose_tissue | 0.57099216 |
| 127 | MP0005187_abnormal_penis_morphology | 0.56718237 |
| 128 | MP0002970_abnormal_white_adipose | 0.56544801 |
| 129 | MP0005448_abnormal_energy_balance | 0.56494660 |
| 130 | MP0008874_decreased_physiological_sensi | 0.55214565 |
| 131 | MP0009764_decreased_sensitivity_to | 0.55077769 |
| 132 | MP0009115_abnormal_fat_cell | 0.54858062 |
| 133 | MP0002837_dystrophic_cardiac_calcinosis | 0.54850485 |
| 134 | MP0002168_other_aberrant_phenotype | 0.54122176 |
| 135 | MP0005166_decreased_susceptibility_to | 0.53357714 |
| 136 | MP0002269_muscular_atrophy | 0.53195408 |
| 137 | MP0002090_abnormal_vision | 0.52993852 |
| 138 | MP0000685_abnormal_immune_system | 0.52660264 |
| 139 | MP0010352_gastrointestinal_tract_polyps | 0.51608325 |
| 140 | MP0001765_abnormal_ion_homeostasis | 0.51404971 |
| 141 | MP0006082_CNS_inflammation | 0.50559815 |
| 142 | MP0005408_hypopigmentation | 0.48659136 |
| 143 | MP0004885_abnormal_endolymph | 0.48414436 |
| 144 | MP0002877_abnormal_melanocyte_morpholog | 0.48367359 |
| 145 | MP0009765_abnormal_xenobiotic_induced | 0.48138467 |
| 146 | MP0005023_abnormal_wound_healing | 0.47934895 |
| 147 | MP0004087_abnormal_muscle_fiber | 0.47551884 |
| 148 | MP0001881_abnormal_mammary_gland | 0.47203866 |
| 149 | MP0008438_abnormal_cutaneous_collagen | 0.46760623 |
| 150 | MP0003172_abnormal_lysosome_physiology | 0.46573506 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 6.04556611 |
| 2 | Eczematoid dermatitis (HP:0000976) | 5.10317394 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 5.05090391 |
| 4 | Xanthomatosis (HP:0000991) | 5.00399579 |
| 5 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.89903286 |
| 6 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.64964396 |
| 7 | Complement deficiency (HP:0004431) | 4.39472125 |
| 8 | Hypobetalipoproteinemia (HP:0003563) | 4.16350559 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 4.14251473 |
| 10 | Mucopolysacchariduria (HP:0008155) | 3.63374426 |
| 11 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.63374426 |
| 12 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.58621374 |
| 13 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.58621374 |
| 14 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.58621374 |
| 15 | Ketosis (HP:0001946) | 3.57691923 |
| 16 | Prolonged partial thromboplastin time (HP:0003645) | 3.51401368 |
| 17 | Epidermoid cyst (HP:0200040) | 3.49112555 |
| 18 | Hypolipoproteinemia (HP:0010981) | 3.45407017 |
| 19 | Abnormality of the common coagulation pathway (HP:0010990) | 3.41600440 |
| 20 | Hyperammonemia (HP:0001987) | 3.40441739 |
| 21 | Hypoalphalipoproteinemia (HP:0003233) | 3.36704316 |
| 22 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.32047860 |
| 23 | Abnormality of macrophages (HP:0004311) | 3.27263219 |
| 24 | Hyperglycinemia (HP:0002154) | 3.21312587 |
| 25 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.18579066 |
| 26 | Hyperglycinuria (HP:0003108) | 3.17344692 |
| 27 | Abnormality of glycine metabolism (HP:0010895) | 3.10936539 |
| 28 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.10936539 |
| 29 | Abnormality of complement system (HP:0005339) | 3.10315046 |
| 30 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.08138297 |
| 31 | Dysostosis multiplex (HP:0000943) | 3.02706217 |
| 32 | Hypoglycemic coma (HP:0001325) | 3.01478362 |
| 33 | Recurrent bacterial skin infections (HP:0005406) | 2.99497645 |
| 34 | Myocardial infarction (HP:0001658) | 2.97925024 |
| 35 | Joint hemorrhage (HP:0005261) | 2.91046173 |
| 36 | Orchitis (HP:0100796) | 2.84299371 |
| 37 | Myositis (HP:0100614) | 2.83901140 |
| 38 | Gout (HP:0001997) | 2.83671525 |
| 39 | Ketoacidosis (HP:0001993) | 2.83020997 |
| 40 | Hypercholesterolemia (HP:0003124) | 2.76775247 |
| 41 | Fat malabsorption (HP:0002630) | 2.74908103 |
| 42 | Hepatocellular carcinoma (HP:0001402) | 2.72647513 |
| 43 | Recurrent abscess formation (HP:0002722) | 2.72550098 |
| 44 | Optic neuritis (HP:0100653) | 2.64163301 |
| 45 | Retrobulbar optic neuritis (HP:0100654) | 2.64163301 |
| 46 | Spastic diplegia (HP:0001264) | 2.62699576 |
| 47 | Mitral stenosis (HP:0001718) | 2.62422460 |
| 48 | Abnormality of glycolipid metabolism (HP:0010969) | 2.59898288 |
| 49 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.59898288 |
| 50 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.59898288 |
| 51 | Interstitial pulmonary disease (HP:0006530) | 2.59483675 |
| 52 | Gingivitis (HP:0000230) | 2.58702641 |
| 53 | Vacuolated lymphocytes (HP:0001922) | 2.56640047 |
| 54 | Hematochezia (HP:0002573) | 2.55678049 |
| 55 | Gastrointestinal infarctions (HP:0005244) | 2.52640299 |
| 56 | Joint swelling (HP:0001386) | 2.52065153 |
| 57 | Abnormality of the intrinsic pathway (HP:0010989) | 2.50934204 |
| 58 | Abnormality of purine metabolism (HP:0004352) | 2.49865948 |
| 59 | Skin nodule (HP:0200036) | 2.48399399 |
| 60 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.46988048 |
| 61 | Back pain (HP:0003418) | 2.46965409 |
| 62 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.46588782 |
| 63 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.43636364 |
| 64 | Pustule (HP:0200039) | 2.43635541 |
| 65 | Abnormal glucose tolerance (HP:0001952) | 2.42100173 |
| 66 | Increased IgE level (HP:0003212) | 2.41518421 |
| 67 | Loss of speech (HP:0002371) | 2.41284508 |
| 68 | Mediastinal lymphadenopathy (HP:0100721) | 2.37750834 |
| 69 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.37668025 |
| 70 | Cholelithiasis (HP:0001081) | 2.36674603 |
| 71 | Abnormality of T cell number (HP:0011839) | 2.36527027 |
| 72 | Abnormality of the lower motor neuron (HP:0002366) | 2.35576891 |
| 73 | T lymphocytopenia (HP:0005403) | 2.34924799 |
| 74 | Esophageal varix (HP:0002040) | 2.33738143 |
| 75 | Abnormality of the Achilles tendon (HP:0005109) | 2.32496897 |
| 76 | Abnormal gallbladder morphology (HP:0012437) | 2.28984752 |
| 77 | Hyperbilirubinemia (HP:0002904) | 2.26175851 |
| 78 | Polycythemia (HP:0001901) | 2.24365390 |
| 79 | Abnormality of nucleobase metabolism (HP:0010932) | 2.22127608 |
| 80 | Spontaneous hematomas (HP:0007420) | 2.19360357 |
| 81 | Glucose intolerance (HP:0000833) | 2.18686741 |
| 82 | Systemic lupus erythematosus (HP:0002725) | 2.18276552 |
| 83 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.16698893 |
| 84 | Vertebral compression fractures (HP:0002953) | 2.14954260 |
| 85 | Pulmonary infiltrates (HP:0002113) | 2.14826647 |
| 86 | Stomatitis (HP:0010280) | 2.14314698 |
| 87 | Abnormality of methionine metabolism (HP:0010901) | 2.14209669 |
| 88 | Neonatal onset (HP:0003623) | 2.13471402 |
| 89 | Abnormal gallbladder physiology (HP:0012438) | 2.13371674 |
| 90 | Cholecystitis (HP:0001082) | 2.13371674 |
| 91 | Global brain atrophy (HP:0002283) | 2.12938116 |
| 92 | Hypochromic anemia (HP:0001931) | 2.12654226 |
| 93 | Sensorimotor neuropathy (HP:0007141) | 2.10192435 |
| 94 | Oligomenorrhea (HP:0000876) | 2.09363804 |
| 95 | Recurrent fungal infections (HP:0002841) | 2.09299032 |
| 96 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.07219508 |
| 97 | Hemorrhage of the eye (HP:0011885) | 2.05854176 |
| 98 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.05575049 |
| 99 | Acanthocytosis (HP:0001927) | 2.05335890 |
| 100 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.05206387 |
| 101 | Pseudobulbar signs (HP:0002200) | 2.03436553 |
| 102 | Abnormality of iron homeostasis (HP:0011031) | 2.02035665 |
| 103 | Hypochromic microcytic anemia (HP:0004840) | 1.99733111 |
| 104 | Deep palmar crease (HP:0006191) | 1.97736388 |
| 105 | Reticulocytosis (HP:0001923) | 1.97585045 |
| 106 | Late onset (HP:0003584) | 1.97508233 |
| 107 | Slow saccadic eye movements (HP:0000514) | 1.97199292 |
| 108 | Menstrual irregularities (HP:0000858) | 1.97051946 |
| 109 | Poikilocytosis (HP:0004447) | 1.95543154 |
| 110 | Malnutrition (HP:0004395) | 1.95280531 |
| 111 | Vascular calcification (HP:0004934) | 1.95020747 |
| 112 | Acne (HP:0001061) | 1.94994402 |
| 113 | Hypoglycemic seizures (HP:0002173) | 1.94184325 |
| 114 | Chronic diarrhea (HP:0002028) | 1.93354966 |
| 115 | Episodic fever (HP:0001954) | 1.93001035 |
| 116 | Recurrent skin infections (HP:0001581) | 1.91928131 |
| 117 | Conjugated hyperbilirubinemia (HP:0002908) | 1.91055351 |
| 118 | Hydroxyprolinuria (HP:0003080) | 1.90246332 |
| 119 | Abnormality of proline metabolism (HP:0010907) | 1.90246332 |
| 120 | Cervical subluxation (HP:0003308) | 1.88820189 |
| 121 | Abnormal pancreas size (HP:0012094) | 1.88606746 |
| 122 | Myoglobinuria (HP:0002913) | 1.88379675 |
| 123 | Abnormal cartilage morphology (HP:0002763) | 1.87363224 |
| 124 | Delayed CNS myelination (HP:0002188) | 1.87156927 |
| 125 | Hemoptysis (HP:0002105) | 1.86830775 |
| 126 | Ovoid vertebral bodies (HP:0003300) | 1.84676921 |
| 127 | Lymphangioma (HP:0100764) | 1.84163541 |
| 128 | J-shaped sella turcica (HP:0002680) | 1.83177451 |
| 129 | Cerebral aneurysm (HP:0004944) | 1.82349777 |
| 130 | Glomerulonephritis (HP:0000099) | 1.81885297 |
| 131 | Steatorrhea (HP:0002570) | 1.81222854 |
| 132 | Cardiovascular calcification (HP:0011915) | 1.80995963 |
| 133 | Increased cerebral lipofuscin (HP:0011813) | 1.80817243 |
| 134 | Stroke (HP:0001297) | 1.80673211 |
| 135 | Irritability (HP:0000737) | 1.80470602 |
| 136 | Abnormality of the gallbladder (HP:0005264) | 1.80446213 |
| 137 | Keratoconjunctivitis (HP:0001096) | 1.80443151 |
| 138 | Hyperglycemia (HP:0003074) | 1.80265902 |
| 139 | Achilles tendon contracture (HP:0001771) | 1.80117579 |
| 140 | Cerebral inclusion bodies (HP:0100314) | 1.79989548 |
| 141 | Cardiomegaly (HP:0001640) | 1.78478968 |
| 142 | Vasculitis (HP:0002633) | 1.77912447 |
| 143 | Increased serum ferritin (HP:0003281) | 1.77812187 |
| 144 | Increased CSF protein (HP:0002922) | 1.77475223 |
| 145 | Type II lissencephaly (HP:0007260) | 1.77173393 |
| 146 | Keratoconjunctivitis sicca (HP:0001097) | 1.75651820 |
| 147 | Distal upper limb amyotrophy (HP:0007149) | 1.75449772 |
| 148 | Upper limb amyotrophy (HP:0009129) | 1.75449772 |
| 149 | Joint stiffness (HP:0001387) | 1.75016438 |
| 150 | Growth hormone excess (HP:0000845) | 1.74423236 |
| 151 | Turricephaly (HP:0000262) | 1.74354504 |
| 152 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.73161720 |
| 153 | Aneurysm (HP:0002617) | 1.72361378 |
| 154 | Colitis (HP:0002583) | 1.71121570 |
| 155 | Increased purine levels (HP:0004368) | 1.71068547 |
| 156 | Hyperuricemia (HP:0002149) | 1.71068547 |
| 157 | Metabolic acidosis (HP:0001942) | 1.70762355 |
| 158 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.70688870 |
| 159 | Mitral valve prolapse (HP:0001634) | 1.70359865 |
| 160 | Hand muscle atrophy (HP:0009130) | 1.70265759 |
| 161 | Urticaria (HP:0001025) | 1.70262290 |
| 162 | Amyloidosis (HP:0011034) | 1.69754180 |
| 163 | Subacute progressive viral hepatitis (HP:0006572) | 1.69709442 |
| 164 | IgM deficiency (HP:0002850) | 1.68425287 |
| 165 | Spontaneous abortion (HP:0005268) | 1.67632655 |
| 166 | Gingival bleeding (HP:0000225) | 1.67431082 |
| 167 | Disproportionate short-trunk short stature (HP:0003521) | 1.66823866 |
| 168 | Testicular neoplasm (HP:0010788) | 1.66754346 |
| 169 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.66650927 |
| 170 | Curly hair (HP:0002212) | 1.66347050 |
| 171 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.65749406 |
| 172 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.65749406 |
| 173 | Anorexia (HP:0002039) | 1.65586664 |
| 174 | Nephritis (HP:0000123) | 1.65525290 |
| 175 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.65464911 |
| 176 | Lymphopenia (HP:0001888) | 1.62011028 |
| 177 | Flat acetabular roof (HP:0003180) | 1.60429032 |
| 178 | Hypoproteinemia (HP:0003075) | 1.59486198 |
| 179 | Meningitis (HP:0001287) | 1.59125618 |
| 180 | Recurrent cutaneous fungal infections (HP:0011370) | 1.59049253 |
| 181 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.59049253 |
| 182 | Hamartoma of the eye (HP:0010568) | 1.58037077 |
| 183 | Hip dysplasia (HP:0001385) | 1.57795691 |
| 184 | Striae distensae (HP:0001065) | 1.56859349 |
| 185 | Osteomyelitis (HP:0002754) | 1.56615132 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 4.66540586 |
| 2 | PKN2 | 3.55793008 |
| 3 | ERN1 | 3.11277225 |
| 4 | SIK1 | 2.99229104 |
| 5 | FGFR4 | 2.90564936 |
| 6 | PRPF4B | 2.68151844 |
| 7 | MAP3K10 | 2.46233891 |
| 8 | PTK6 | 2.32229918 |
| 9 | EEF2K | 2.29138632 |
| 10 | IRAK4 | 2.24066774 |
| 11 | BCKDK | 2.23014318 |
| 12 | RIPK1 | 2.19090544 |
| 13 | TNK2 | 1.91482845 |
| 14 | FES | 1.86134686 |
| 15 | SIK3 | 1.82797324 |
| 16 | EPHB1 | 1.69420282 |
| 17 | NLK | 1.68029158 |
| 18 | TTN | 1.65097976 |
| 19 | KSR2 | 1.62727935 |
| 20 | PDGFRA | 1.52251503 |
| 21 | MAP4K1 | 1.50197986 |
| 22 | BLK | 1.49057120 |
| 23 | MAP3K7 | 1.46054299 |
| 24 | CAMK1D | 1.43848229 |
| 25 | IKBKE | 1.42364522 |
| 26 | ICK | 1.41286129 |
| 27 | GRK6 | 1.39548515 |
| 28 | TAOK3 | 1.39474607 |
| 29 | MAP3K2 | 1.39024248 |
| 30 | CAMK1G | 1.38306918 |
| 31 | TYK2 | 1.34075139 |
| 32 | BTK | 1.33579620 |
| 33 | HIPK2 | 1.33511243 |
| 34 | LATS1 | 1.30416226 |
| 35 | JAK1 | 1.29792291 |
| 36 | TXK | 1.29770824 |
| 37 | SMG1 | 1.29007149 |
| 38 | MAP3K11 | 1.27265433 |
| 39 | LRRK2 | 1.26977728 |
| 40 | RET | 1.25285051 |
| 41 | JAK2 | 1.18776356 |
| 42 | TYRO3 | 1.18666937 |
| 43 | CAMKK2 | 1.13584951 |
| 44 | FGFR2 | 1.10900083 |
| 45 | MAP2K6 | 1.10885613 |
| 46 | MST1R | 1.06678047 |
| 47 | BMX | 1.06133852 |
| 48 | FGFR3 | 1.06038229 |
| 49 | TAOK1 | 1.02859678 |
| 50 | PRKCH | 1.02648056 |
| 51 | PAK6 | 1.00787060 |
| 52 | ALK | 1.00032610 |
| 53 | FGR | 0.97461248 |
| 54 | PTK2 | 0.96711728 |
| 55 | CDK12 | 0.96373746 |
| 56 | DYRK1B | 0.95874870 |
| 57 | DAPK2 | 0.95477768 |
| 58 | AKT3 | 0.94322619 |
| 59 | CDK6 | 0.93923704 |
| 60 | ACVR1B | 0.92407481 |
| 61 | MAP2K4 | 0.91151063 |
| 62 | MTOR | 0.90459609 |
| 63 | CSK | 0.89651045 |
| 64 | IRAK3 | 0.88690221 |
| 65 | PDGFRB | 0.88603326 |
| 66 | BMPR1B | 0.88318497 |
| 67 | MAP3K9 | 0.87733775 |
| 68 | TRPM7 | 0.86395952 |
| 69 | MAPK11 | 0.85469761 |
| 70 | SIK2 | 0.82836900 |
| 71 | MARK3 | 0.82800761 |
| 72 | SCYL2 | 0.82296632 |
| 73 | TGFBR2 | 0.80603886 |
| 74 | PDPK1 | 0.80575852 |
| 75 | IKBKB | 0.80425548 |
| 76 | IRAK1 | 0.79990188 |
| 77 | FLT3 | 0.79021847 |
| 78 | NUAK1 | 0.78760037 |
| 79 | LCK | 0.78314068 |
| 80 | MAPKAPK3 | 0.78231688 |
| 81 | STK10 | 0.77998806 |
| 82 | MAP2K3 | 0.77912096 |
| 83 | ITK | 0.75890353 |
| 84 | CAMKK1 | 0.74084017 |
| 85 | PDK1 | 0.73672235 |
| 86 | CDC42BPA | 0.73651746 |
| 87 | SGK3 | 0.72919729 |
| 88 | MET | 0.71802130 |
| 89 | TESK1 | 0.71313327 |
| 90 | INSRR | 0.69460336 |
| 91 | PAK3 | 0.68999858 |
| 92 | PRKAA2 | 0.68467822 |
| 93 | TBK1 | 0.65753297 |
| 94 | PRKAA1 | 0.65308531 |
| 95 | FRK | 0.64979606 |
| 96 | STK38 | 0.64535114 |
| 97 | PAK2 | 0.63756780 |
| 98 | PRKD1 | 0.63161796 |
| 99 | ADRBK2 | 0.61903577 |
| 100 | ZAP70 | 0.61191343 |
| 101 | SGK2 | 0.61160710 |
| 102 | SYK | 0.60922056 |
| 103 | TLK1 | 0.60894738 |
| 104 | MAP3K1 | 0.60877699 |
| 105 | PRKCQ | 0.60020355 |
| 106 | LYN | 0.58512543 |
| 107 | GSK3A | 0.56708408 |
| 108 | SGK223 | 0.55246633 |
| 109 | SGK494 | 0.55246633 |
| 110 | NEK1 | 0.53481208 |
| 111 | CAMK4 | 0.53032768 |
| 112 | STK11 | 0.52855882 |
| 113 | LMTK2 | 0.52576432 |
| 114 | KDR | 0.51566547 |
| 115 | MAP2K1 | 0.51519776 |
| 116 | JAK3 | 0.51101827 |
| 117 | MAP3K13 | 0.50760712 |
| 118 | PHKG1 | 0.49939441 |
| 119 | PHKG2 | 0.49939441 |
| 120 | ERBB2 | 0.49608751 |
| 121 | PRKD3 | 0.49107147 |
| 122 | MELK | 0.48928995 |
| 123 | ERBB4 | 0.48604374 |
| 124 | CSF1R | 0.46324945 |
| 125 | TRIM28 | 0.46183401 |
| 126 | CDK4 | 0.45823618 |
| 127 | PIK3CG | 0.45159000 |
| 128 | PRKCZ | 0.45023321 |
| 129 | FER | 0.44995526 |
| 130 | MAPK12 | 0.44514334 |
| 131 | HCK | 0.44353221 |
| 132 | PRKD2 | 0.44309542 |
| 133 | STK3 | 0.44293813 |
| 134 | RIPK4 | 0.43978943 |
| 135 | EGFR | 0.42995409 |
| 136 | VRK1 | 0.42843902 |
| 137 | FGFR1 | 0.40981897 |
| 138 | EPHA3 | 0.40221143 |
| 139 | MAP2K2 | 0.40203765 |
| 140 | MAP3K3 | 0.39324340 |
| 141 | WNK4 | 0.38903473 |
| 142 | MARK2 | 0.38595071 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 4.17182170 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.72101267 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.39874620 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.94636588 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.93507238 |
| 6 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.47423771 |
| 7 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.33488512 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.31906408 |
| 9 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.26829233 |
| 10 | Other glycan degradation_Homo sapiens_hsa00511 | 2.25991892 |
| 11 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.14919083 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.14139799 |
| 13 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.04414203 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.94491715 |
| 15 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.94127933 |
| 16 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.87858535 |
| 17 | Bile secretion_Homo sapiens_hsa04976 | 1.79871031 |
| 18 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.72379505 |
| 19 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.71082794 |
| 20 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.71066896 |
| 21 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.63801453 |
| 22 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.61660519 |
| 23 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.58455715 |
| 24 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.55282337 |
| 25 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.46499608 |
| 26 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.45451436 |
| 27 | Peroxisome_Homo sapiens_hsa04146 | 1.43514226 |
| 28 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.42281528 |
| 29 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.40072335 |
| 30 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.39469026 |
| 31 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.34302270 |
| 32 | Histidine metabolism_Homo sapiens_hsa00340 | 1.31666384 |
| 33 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.31359624 |
| 34 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.30736538 |
| 35 | ABC transporters_Homo sapiens_hsa02010 | 1.29940312 |
| 36 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.29019919 |
| 37 | Hepatitis C_Homo sapiens_hsa05160 | 1.28196469 |
| 38 | Measles_Homo sapiens_hsa05162 | 1.26029459 |
| 39 | Lysine degradation_Homo sapiens_hsa00310 | 1.25983105 |
| 40 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.25699869 |
| 41 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.23516518 |
| 42 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.21365152 |
| 43 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.20762029 |
| 44 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.19922920 |
| 45 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.17981192 |
| 46 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.15916227 |
| 47 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.15309879 |
| 48 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.12758613 |
| 49 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.12735689 |
| 50 | Carbon metabolism_Homo sapiens_hsa01200 | 1.12452202 |
| 51 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.11584926 |
| 52 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.09331092 |
| 53 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.08529708 |
| 54 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.06679396 |
| 55 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.06357793 |
| 56 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.05502327 |
| 57 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.02948325 |
| 58 | Retinol metabolism_Homo sapiens_hsa00830 | 1.01686309 |
| 59 | Tuberculosis_Homo sapiens_hsa05152 | 1.01233620 |
| 60 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.98681694 |
| 61 | Hepatitis B_Homo sapiens_hsa05161 | 0.98193700 |
| 62 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.96204629 |
| 63 | Insulin resistance_Homo sapiens_hsa04931 | 0.93978493 |
| 64 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.93852359 |
| 65 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.92875377 |
| 66 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.92051443 |
| 67 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.90922031 |
| 68 | Endocytosis_Homo sapiens_hsa04144 | 0.90500478 |
| 69 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.90178385 |
| 70 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.89636298 |
| 71 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.87937750 |
| 72 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.86476408 |
| 73 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.85038501 |
| 74 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.84859359 |
| 75 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.84751455 |
| 76 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.83497165 |
| 77 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.82929291 |
| 78 | Leishmaniasis_Homo sapiens_hsa05140 | 0.82181853 |
| 79 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.81808423 |
| 80 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.81678408 |
| 81 | Phagosome_Homo sapiens_hsa04145 | 0.80652672 |
| 82 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.80415050 |
| 83 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.79131458 |
| 84 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.77860472 |
| 85 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.77232588 |
| 86 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.76125826 |
| 87 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.75837489 |
| 88 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.75231124 |
| 89 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.74929682 |
| 90 | Apoptosis_Homo sapiens_hsa04210 | 0.73022627 |
| 91 | Influenza A_Homo sapiens_hsa05164 | 0.72711912 |
| 92 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.69866411 |
| 93 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.69622331 |
| 94 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.69054901 |
| 95 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.68887368 |
| 96 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.68844770 |
| 97 | Allograft rejection_Homo sapiens_hsa05330 | 0.68459960 |
| 98 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.68327217 |
| 99 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.64080315 |
| 100 | Sulfur relay system_Homo sapiens_hsa04122 | 0.62766637 |
| 101 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.62478053 |
| 102 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.62053601 |
| 103 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.61724755 |
| 104 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.61143429 |
| 105 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.60587276 |
| 106 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.58226689 |
| 107 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.57710648 |
| 108 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.57640721 |
| 109 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.56088444 |
| 110 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.55443510 |
| 111 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.55017102 |
| 112 | Platelet activation_Homo sapiens_hsa04611 | 0.54394502 |
| 113 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.53485199 |
| 114 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.53202247 |
| 115 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.53157831 |
| 116 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.52710926 |
| 117 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.51089270 |
| 118 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.51007226 |
| 119 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.50511528 |
| 120 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.49778869 |
| 121 | Colorectal cancer_Homo sapiens_hsa05210 | 0.49686445 |
| 122 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.49683458 |
| 123 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.49283002 |
| 124 | Prion diseases_Homo sapiens_hsa05020 | 0.48466999 |
| 125 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.48447532 |
| 126 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.48029402 |
| 127 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.43371544 |
| 128 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.39383795 |
| 129 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.37851124 |
| 130 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.37820573 |
| 131 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.35258245 |
| 132 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.34199098 |
| 133 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.31426616 |
| 134 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.30295049 |
| 135 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.29044982 |
| 136 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.26002857 |
| 137 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.24028298 |
| 138 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.23402151 |
| 139 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.22253348 |
| 140 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.21788893 |
| 141 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.21605058 |
| 142 | Amoebiasis_Homo sapiens_hsa05146 | 0.21301108 |
| 143 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.20047914 |
| 144 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.19789765 |
| 145 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.19572033 |
| 146 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.18448905 |
| 147 | Lysosome_Homo sapiens_hsa04142 | 0.18318590 |
| 148 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.17560389 |
| 149 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.15573218 |
| 150 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.14616823 |
| 151 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.14585951 |
| 152 | Endometrial cancer_Homo sapiens_hsa05213 | 0.13678390 |
| 153 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.13004809 |
| 154 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.12334875 |
| 155 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.12057864 |
| 156 | Bladder cancer_Homo sapiens_hsa05219 | 0.11666650 |
| 157 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.11088237 |

